Osmotic pump with means for dissipating internal pressure

Details for Australian Patent Application No. 2004227985 (hide)

Owner Intarcia Therapeutics, Inc.

Inventors Davis, Craig; Dionne, Keith; Mosbauer, Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004227985

PCT Pub. Number WO2004/089457

Priority 60/459,296 31.03.03 US

Filing date 31 March 2004

Wipo publication date 21 October 2004

Acceptance publication date 2 April 2009

International Classifications

A61M 31/00 (2006.01) Devices for introducing or retaining media, e.g. remedies, in cavities of the body

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61M 5/145 (2006.01) Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way - using pressurised reservoirs, e.g. by means of pistons

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/089457 Priority application(s): WO2004/089457

1 May 2008 Assignment before Grant

  Alza Corporation The application has been assigned to Intarcia Therapeutics, Inc.

2 April 2009 Application Accepted

  Published as AU-B-2004227985

30 July 2009 Standard Patent Sealed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227986-Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems

2004227983-Polyamine compounds for treating chemokine receptor mediated diseases